Perspective
Federal Government Should Advise on Drug Negotiations, Not Run Them
September 23, 2021
Featured Experts: Karen Mulligan, PhD, Darius Lakdawalla, PhD
Research
All Research Featured Research
Journal Article
Measuring the COVID-19 Mortality Burden in the United States
September 21, 2021
Featured Experts: Hanke Heun-Johnson, PhD, Bryan Tysinger, PhD, Darius Lakdawalla, PhD
Journal Article
A Guide to Extending and Implementing Generalized Risk‑Adjusted Cost‑Effectiveness
September 8, 2021
Featured Experts: Darius Lakdawalla, PhD, Charles E. Phelps, PhD
Journal Article
Generalized Risk-Adjusted Cost-Effectiveness (GRACE): Ensuring Patient-Centered Outcomes in Healthcare Decision Making
September 1, 2021
Featured Experts: Darius Lakdawalla, PhD, Charles E. Phelps, PhD
Journal Article
Challenging Assumptions of Outcomes and Costs Comparing Peritoneal and Hemodialysis
July 30, 2021
Featured Experts: Eugene Lin, MD, MS, Khristina Ipapo Lung, MPH, Darius Lakdawalla, PhD, Jay Bhattacharya, MD, PhD
White Paper
Reducing Racial Disparities in Early Cancer Diagnosis With Blood-Based Tests
July 12, 2021
Featured Experts: Alison Sexton Ward, PhD, Karen Van Nuys, PhD, Darius Lakdawalla, PhD
Perspective
FDA’s Approval of Aducanumab Paves the Way for ‘More Momentous’ Alzheimer’s Breakthroughs
June 7, 2021
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD
White Paper
Impacts of First-in-Class Drug Approvals on Future in-Class Innovation
May 20, 2021
Featured Experts: Alison Sexton Ward, PhD, Karen Van Nuys, PhD, Darius Lakdawalla, PhD
Journal Article
Association of Drug Rebates and Competition With Out-of-Pocket Coinsurance in Medicare Part D, 2014 to 2018
May 7, 2021
Featured Experts: Darius Lakdawalla, PhD
Perspective
Don’t Make Surgery Another COVID Casualty
April 29, 2021
Featured Experts: Karen Van Nuys, PhD, Darius Lakdawalla, PhD
Case Study
Schaeffer Solutions: Reining in Prescription Drug Costs
April 24, 2021
Featured Experts: Neeraj Sood, PhD, Karen Van Nuys, PhD, Darius Lakdawalla, PhD, Dana Goldman, PhD, Erin Trish, PhD
News
Minimally Invasive Surgeries Offer Strategies for Hospitals to Create Surge Capacity
March 17, 2021
Featured Experts: Darius Lakdawalla, PhD, Karen Van Nuys, PhD
White Paper
Reassessing the Value of Minimally Invasive Technologies in the Era of COVID-19
March 17, 2021
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD, Karen Van Nuys, PhD
Journal Article
The Economics of Alternative Payment Models for Pharmaceuticals
March 16, 2021
Featured Experts: Jakub Hlávka, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD
Perspective
Create a U.S. Institute of Health Technology Assessment to Preserve Innovation and Control Costs
March 5, 2021
Featured Experts: Darius Lakdawalla, PhD
White Paper
Health Technology Assessment in the U.S. – A Vision for the Future
February 9, 2021
Featured Experts: Darius Lakdawalla, PhD, William Padula, PhD, Charles E. Phelps, PhD, Dana Goldman, PhD, Karen Mulligan, PhD, Desi Peneva, MS
Journal Article
Health Technology Assessment with Diminishing Returns to Health: The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Approach
January 12, 2021
Featured Experts: Darius Lakdawalla, PhD, Charles E. Phelps, PhD
Journal Article
Predicting Quantity and Quality of Life with the Future Elderly Model
October 16, 2020
Featured Experts: Duncan Ermini Leaf, PhD, Bryan Tysinger, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD
Perspective
Group Testing for Coronavirus – Called Pooled Testing – Could Be the Fastest and Cheapest Way to Increase Screening Nationwide
July 2, 2020
Featured Experts: Darius Lakdawalla, PhD, Erin Trish, PhD